Two new studies provided information on the latest news of ovarian cancer
Australian research shows that green tea can prevent a Gallup poll ovarian cancer and extend life China news agency, Sydney, September 19-House in Perth, Western Australia's University of Science and Technology Keding a latest study,...
Group of protein in ovarian cancer diagnosis of Ovarian cancer is the female reproductive system cancer one of the three, as misprision of clinical symptoms, the lack of an effective meth...
【Medical industry network HealthDayNews2003 According to the July 3 - now on the younger female epithelial ovarian cancer, some important information: your chances of survival much more than older patients.
In July, "Obstetrics and Gynecology" (Obstetrics andGynecology), the journal published a new study, the researchers found: diagnosis of advanced epithelial ovarian cancer in women aged under 45 of the 5-year survival than those over the age of 45 is two times bigger. "If all other aspects of the same, young patients can live better," the author, Stamford University professor Chen (JohnChan): In fact, even if it is possible to study the impact of factors, such as other health problems, age patients still live better.
Epithelial ovarian cancer is the most common ovarian cancer, accounting for 90%. While researchers said they do not know why the survival rate of young patients better, but guess might be "elderly patients and young patients tumor biology (such as background hormones, growth factors, angiogenesis and growth regulators) and the different immune responses."
This study by the University of California, Zhao Comprehensive Cancer Center, a total of 104 advanced epithelial ovarian cancer, of whom 52 were less than 45 years old. Examined the medical records of patients, the researchers found that elderly patients in five-year survival rate is 22%, with an average survival time of 34 months, and quite different from younger patients, the average survival time of 54 months, 5-year survival rate was 48%. Another difference: diagnosis and classification of cancer by surgery type also affects the survival of the two groups.
The Pacific Northwest Research Institute scientists in the other on ovarian cancer found in a study of this disease in a new marker, which could lead to the emergence of new blood tests to earlier diagnosis of ovarian cancer and improving the cure rate. The logo of the promoter, and it seems that the expression of ovarian cancer, said sensitivity than CA125 (currently used to detect blood samples of ovarian cancer marker) the 40%, but that is done by the promoter of a lower false positive rate, cancer is found early, and found a CA125 late. In July, "Cancer Research" magazine (CancerResearch), the author said that in deciding whether to be the promoter of clinical detection methods are needed before further experiments.
Ovarian cancer prevention three glasses of tea a day According to this morning's Morning News, published in December of this year - the "scientific literature" magazine, a new st...
Depression risk of ovarian cancer women Researchers in the United States recently claimed that women Wan children may reduce the risk of ovarian cancer. The University of Southern...
Depression in women ovarian cancer susceptibility Researchers in the United States recently claimed that women Wan children may reduce the risk of ovarian cancer. The University of Souther...
Metastatic ovarian cancer diagnosis Because some patients with abdominal mass for the first symptom, the disease easily confused with primary ovarian cancer. While most patient...
Protein detection help in the early diagnosis of ovarian cancer The latest research report, researchers in the search for a new blood test to help early diagnosis of ovarian cancer progress, the rate of p...
Dietary calcium and more small risk of ovarian cancer Dietary calcium most women suffering from ovarian cancer may be smaller than the lowest 54%, although further research needed to confirm the...
Uterine fibroids, ovarian cysts latest therapy
Tags: age, blood, cancer, clinical, diagnosis, early, gene, group, groups, growth, method, ovarian, patients, positive, rate, response, study, surgery, survival, time, tumor, women